INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 47m ago
HOUSE PTR7m ago
SEC 13F7m ago
ROBINHOOD CHAIN7m ago
Public company

HRMYHarmony Biosciences Holdings, Inc.

CIK 0001802665

EDGAR filingsOpen in network
Disclosed transactions58
Buys / sells0 / 8
Max Insider Score38
Connections7with evidence

HRMY · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
21
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Open-market sale
SELL$34K
800 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Philip Ron MDirector · May 18, 2026
  • ← Insider ofevidence
    Anastasiou PeterCHIEF OPERATING OFFICER · Apr 6, 2026
  • ← Insider ofevidence
    Serafin AndrewCHIEF STRATEGY OFFICER · Jan 26, 2026
5
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M
$12K
400 sh
Sep 17, 2026
Sep 18, 2026
traded Sep 17, 2026
+1d
SEC FORM 4

Evidence

35
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Open-market sale
SELL$1.54M
35.9K sh
Sep 18, 2026Sep 18, 2026
traded Sep 18, 2026
+0dSEC FORM 4

Evidence

9
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M$28K
900 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC FORM 4

Evidence

5
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M$12K
400 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC FORM 4

Evidence

20
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M$319K
10.4K sh
Sep 18, 2026Sep 18, 2026
traded Sep 18, 2026
+0dSEC FORM 4

Evidence

20
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M$770K
25.4K sh
Sep 18, 2026Sep 18, 2026
traded Sep 18, 2026
+0dSEC FORM 4

Evidence

24
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Open-market sale
SELL$77K
1,800 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC FORM 4

Evidence

14
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
25.4K sh
Sep 18, 2026Sep 18, 2026
traded Sep 18, 2026
+0dSEC FORM 4

Evidence

14
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
10.4K sh
Sep 18, 2026Sep 18, 2026
traded Sep 18, 2026
+0dSEC FORM 4

Evidence

5
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
400 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC FORM 4

Evidence

5
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
900 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC FORM 4

Evidence

5
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
400 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC FORM 4

Evidence

5
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
900 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC FORM 4

Evidence

9
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M$27K
900 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC FORM 4

Evidence

21
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Open-market sale
SELL$43K
1,000 sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC FORM 4

Evidence

38
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Open-market sale
SELL$231K
5,500 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC FORM 4

Evidence

28
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Open-market sale
SELL$190K
4,500 sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC FORM 4

Evidence

23
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M$374K
12.2K sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC FORM 4

Evidence

19
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M$326K
10.8K sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC FORM 4

Evidence

17
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
12.2K sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC FORM 4

Evidence

13
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
10.8K sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC FORM 4

Evidence

35
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Open-market sale
SELL$989K
23.0K sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC FORM 4

Evidence

31
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
18.8K sh
May 1, 2026May 18, 2026
traded May 1, 2026
+17dSEC FORM 4

Evidence

9
PM
Philip Ron MDirector
HRMYHarmony Biosciences Holdings, Inc.
Grant or award
A—
21.9K sh
May 14, 2026May 18, 2026
traded May 14, 2026
+4dSEC FORM 4

Evidence

37
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Tax withholding
F$283K
8,882 sh
May 1, 2026May 18, 2026
traded May 1, 2026
+17dSEC FORM 4

Evidence

31
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
18.8K sh
May 1, 2026May 18, 2026
traded May 1, 2026
+17dSEC FORM 4

Evidence

24
ZH
Zaeske Adam H.CHIEF COMMERCIAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Tax withholding
F$88K
3,173 sh
Apr 7, 2026Apr 9, 2026
traded Apr 7, 2026
+2dSEC FORM 4

Evidence

9
ZH
Zaeske Adam H.CHIEF COMMERCIAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
7,500 sh
Apr 7, 2026Apr 9, 2026
traded Apr 7, 2026
+2dSEC FORM 4

Evidence

9
ZH
Zaeske Adam H.CHIEF COMMERCIAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
7,500 sh
Apr 7, 2026Apr 9, 2026
traded Apr 7, 2026
+2dSEC FORM 4

Evidence

9
AP
Anastasiou PeterCHIEF OPERATING OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Grant or award
A—
212.2K sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC FORM 4

Evidence

12
KS
Kapadia SandipCHIEF FINANCIAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$139K
3,746 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC FORM 4

Evidence

9
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Grant or award
A—
12.2K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC FORM 4

Evidence

21
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
2,188 sh
Jan 24, 2026Jan 26, 2026
traded Jan 24, 2026
+2dSEC FORM 4

Evidence

9
SA
Serafin AndrewCHIEF STRATEGY OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
2,500 sh
Jan 24, 2026Jan 26, 2026
traded Jan 24, 2026
+2dSEC FORM 4

Evidence

21
SA
Serafin AndrewCHIEF STRATEGY OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Tax withholding
F$41K
1,116 sh
Jan 24, 2026Jan 26, 2026
traded Jan 24, 2026
+2dSEC FORM 4

Evidence

9
SA
Serafin AndrewCHIEF STRATEGY OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
2,600 sh
Jan 25, 2026Jan 26, 2026
traded Jan 25, 2026
+1dSEC FORM 4

Evidence

21
SA
Serafin AndrewCHIEF STRATEGY OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Tax withholding
F$41K
1,126 sh
Jan 25, 2026Jan 26, 2026
traded Jan 25, 2026
+1dSEC FORM 4

Evidence

9
SA
Serafin AndrewCHIEF STRATEGY OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Grant or award
A—
42.6K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC FORM 4

Evidence

9
SA
Serafin AndrewCHIEF STRATEGY OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Grant or award
A—
12.2K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC FORM 4

Evidence

21
SA
Serafin AndrewCHIEF STRATEGY OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
2,500 sh
Jan 24, 2026Jan 26, 2026
traded Jan 24, 2026
+2dSEC FORM 4

Evidence

21
SA
Serafin AndrewCHIEF STRATEGY OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
2,600 sh
Jan 25, 2026Jan 26, 2026
traded Jan 25, 2026
+1dSEC FORM 4

Evidence

9
KS
Kapadia SandipCHIEF FINANCIAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
3,813 sh
Jan 24, 2026Jan 26, 2026
traded Jan 24, 2026
+2dSEC FORM 4

Evidence

12
KS
Kapadia SandipCHIEF FINANCIAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Tax withholding
F$82K
2,239 sh
Jan 24, 2026Jan 26, 2026
traded Jan 24, 2026
+2dSEC FORM 4

Evidence

9
KS
Kapadia SandipCHIEF FINANCIAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
4,725 sh
Jan 25, 2026Jan 26, 2026
traded Jan 25, 2026
+1dSEC FORM 4

Evidence

12
KS
Kapadia SandipCHIEF FINANCIAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Tax withholding
F$94K
2,553 sh
Jan 25, 2026Jan 26, 2026
traded Jan 25, 2026
+1dSEC FORM 4

Evidence

9
KS
Kapadia SandipCHIEF FINANCIAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Grant or award
A—
42.6K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC FORM 4

Evidence

9
KS
Kapadia SandipCHIEF FINANCIAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Grant or award
A—
12.2K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC FORM 4

Evidence

21
KS
Kapadia SandipCHIEF FINANCIAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
3,813 sh
Jan 24, 2026Jan 26, 2026
traded Jan 24, 2026
+2dSEC FORM 4

Evidence

21
KS
Kapadia SandipCHIEF FINANCIAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
4,725 sh
Jan 25, 2026Jan 26, 2026
traded Jan 25, 2026
+1dSEC FORM 4

Evidence

17
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
2,662 sh
Jan 25, 2026Jan 26, 2026
traded Jan 25, 2026
+1dSEC FORM 4

Evidence

9
ZH
Zaeske Adam H.CHIEF COMMERCIAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Grant or award
A—
56.9K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC FORM 4

Evidence

9
ZH
Zaeske Adam H.CHIEF COMMERCIAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Grant or award
A—
16.2K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC FORM 4

Evidence

9
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
2,188 sh
Jan 24, 2026Jan 26, 2026
traded Jan 24, 2026
+2dSEC FORM 4

Evidence

9
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Tax withholding
F$42K
1,153 sh
Jan 24, 2026Jan 26, 2026
traded Jan 24, 2026
+2dSEC FORM 4

Evidence

9
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
2,662 sh
Jan 25, 2026Jan 26, 2026
traded Jan 25, 2026
+1dSEC FORM 4

Evidence

12
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Tax withholding
F$51K
1,372 sh
Jan 25, 2026Jan 26, 2026
traded Jan 25, 2026
+1dSEC FORM 4

Evidence

9
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Grant or award
A—
42.6K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Zaeske Adam H.CHIEF COMMERCIAL OFFICER · Jan 26, 2026
  • ← Insider ofevidence
    Kapadia SandipCHIEF FINANCIAL OFFICER · Jan 26, 2026
  • ← Insider ofevidence
    Budur KumarCHIEF MEDICAL OFFICER · Jan 26, 2026